Skip Navigation


European Heart Journal Advance Access originally published online on June 26, 2008
European Heart Journal 2008 29(16):1930-1931; doi:10.1093/eurheartj/ehn304
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/16/1930    most recent
ehn304v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Niemelä, K. O.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Niemelä, K. O.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author 2008. For permissions please email: journals.permissions@oxfordjournals.org

Biodegradable coating for drug-eluting stents—more than a facelift?

Kari O. Niemelä*

Heart Center, Tampere University Hospital, FI-33521 Tampere, Finland

* Corresponding author. Tel: +358 3 247 5111, Fax: +358 3 247 4157, Email: kari.niemela@pshp.fi

This editorial refers to ‘Randomized trial of three rapamycin-eluting stents with different coating strategies for the reduction of coronary restenosis’{dagger} by J. Mehilli et al., on page 1975

Footnotes

The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.

The first 10% of the full text of this article appears below.

Since its introduction 1977, percutaneous coronary angioplasty (PCI) has developed into the most common revascularization method of coronary artery disease (nearly 2 million procedures in Europe in 2003).1,2 Early complications of ‘plain old’ balloon angioplasty such as acute recoil and abrupt vessel closure were markedly reduced by bare metal stents (BMS; in 1987) providing mechanical scaffolding of the vessel.3 Metallic stents thereby not only reduced the need for emergency coronary artery bypass grafting to <0.5% but nearly halved high restenosis rates . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?